Depression is one of the most common mental health conditions in the U.S., characterized by symptoms such as sadness, loss of pleasure, low energy, trouble concentrating, and suicidal thoughts. Causes often stem from a mix of biological, psychological, and social factors that alter brain function, leading to changes in neural activity. Auditory and visual processing problems are often underlying contributors to these symptoms, typically beyond the individual's awareness or control.
As of 2023, approximately 30% of U.S. adults report symptoms of anxiety and/or depression, a decrease from the 40% peak in early 2021 but still higher than pre-pandemic levels. Depression prevalence spiked more than threefold during the COVID-19 pandemic, rising from 8.5% to 27.8% in early 2020. Young adults (ages 18-29) are particularly affected, with nearly 35% reporting symptoms of depression in 2023. Rates are also higher among women (36%) compared to men (28%), and those facing job loss report much higher depression rates (53%) than those without job loss (30%).
Neurofeedback can help reduce symptoms of depression by adjusting brainwave activity. Research shows that individuals with depression often have an imbalance in brain activity, with greater alpha wave activity in the left frontal region, indicating reduced left-side activation. This asymmetry is associated with lower mood, and neurofeedback can train the brain to restore balance, enhancing left frontal activation and promoting a more positive mood. This approach has shown promise in clinical settings as a non-invasive method to support mood improvement, complementing other therapies for depression. Unlike medication, neurofeedback carries few side effects, with the most common being a temporary feeling of tiredness after a session.
Comments